🔍 Key Findings

• Perioperative mortality rate was low (2.9%), with no intraoperative deaths reported.
• Intraoperative complications occurred in 54.3% of dogs, most commonly hemorrhage and cardiovascular events.
• 21% of dogs required blood transfusions, though transfusion was not associated with higher complication risk.
• Advanced hemodynamic support (fluid + cardiovascular) was significantly associated with short-term complications (OR 17.3, p = .029) and shorter survival.
• No surgical method (e.g., TA stapler, vessel sealing device, hilar resection) was associated with increased risk of complications.
• Hepatocellular carcinoma (HCC) was the most common diagnosis (53%), with an MST of 741 days and 17.6% recurrence.
• Surgical margins (complete vs incomplete) were not associated with overall survival time in dogs with HCC.
• The use of preoperative CT and improved surgical instrumentation may have contributed to the lower observed mortality.

🔍 Key Findings

• Heated CO₂ insufflation reduced perioperative hypothermia during laparoscopic ovariectomy compared to nonheated CO₂.
• Final body temperature was significantly higher in the heated group (36.03°C) than in the nonheated group (34.93°C).
• Temperature reduction correlated with surgical duration only in the nonheated group (p < .05).
• Heated CO₂ delayed temperature drop, occurring after 20 minutes vs. 5 minutes in nonheated cases.
• No significant differences between groups in anesthetic, surgical, or insufflation times.
• All dogs recovered uneventfully and were discharged the same day.
• Heated CO₂ may offer greater benefit in longer procedures or in small-sized dogs prone to hypothermia.
• No adverse effects were attributed to heated gas use in this clinical trial.

🔍 Key Findings

• Laparoscopic cholecystectomy (LC) was successfully performed in all 22 cats without conversion to open surgery.
• Complication rate was low: 3 cats had postoperative complications (1 seroma, 1 vomiting, 1 EHBDO and death).
• Median operating time was 41 minutes; median hospitalization was 3 days.
• No cases required conversion to open laparotomy, even in cats as small as 2.5 kg.
• Common devices used: Hemoclips or Hem-o-lok for cystic duct ligation; Ligasure, harmonic scalpel, or j-hook for dissection.
• Most common indications: cholelithiasis (9/22) and cholecystitis (10/22), with one biliary mucocele and one adenoma.
• Histopathology confirmed diagnosis in all cases; concurrent liver or intestinal biopsies were performed in some cats.
• Postoperative AUS and bloodwork were routine and important for detecting early signs of EHBDO.

🔍 Key Findings Summary

• Evaluated ideal dorsolateral implant trajectories in T1–T13 using CT in 30 dogs across five weight classes.
• Corridor widths were narrowest in the mid-thoracic vertebrae (as little as 1.8 mm) and increased cranially and caudally.
• Allowable deviation angles (ADA) were often very small (as little as 3°), indicating high risk for canal or thoracic structure breach.
• Distances to critical structures (lungs, aorta, subclavian artery, azygos vein) were often <1 mm, even in large dogs.
• Data suggest extreme caution and precision are needed for thoracic vertebral implant placement and support use of navigation or 3D-printed guides.

🔍 Key Findings

• Only 1 of 12 dogs (8.3%) cultured the same single organism (Staphylococcus schleiferi) at TECA and dehiscence sites.
• In 58.3% (7/12), none of the bacteria from TECA cultures were found at dehiscence.
• Staphylococcus spp. were isolated in 83.3% of dehiscence samples.
• Methicillin resistance was high among Staphylococcus isolates: 80% at dehiscence.
• Antibiotic susceptibility differed in 57% (4/7) of cases where the same bacteria were cultured at both time points.
• TECA cultures were not predictive of bacteria at incisional dehiscence.
• 75% of dogs healed with either medical or surgical management.

Recommendation: Repeat cultures at dehiscence to guide antibiotic therapy.

🔍 Key Findings

• Prophylactic fenestration (PF) significantly reduced recurrence of cervical intervertebral disc extrusion (0% vs. 37.8%, p < .001).
• Surgery time was longer with PF (median 182 vs. 110 min, p = .017), but no difference in perioperative complication rates (PF 16.7%, non-PF 18.9%; p = .838).
• 25% overall recurrence rate, but all recurrences occurred in the non-PF group.
• Medical management was effective in 92.9% of recurrence cases.
• Most PF sites targeted adjacent discs; 88.9% were at adjacent levels, which are common recurrence sites.
• Neurologic outcomes were similar between PF and non-PF dogs post-surgery and at follow-up.
• Fenestration technique (blade vs. burr) not shown to affect outcome but contributed to extended surgical time.
• No major complications or deaths linked directly to PF in initial surgeries.

🔍 Key Findings

• Portal pressure increased proportionally with insufflation pressure: 38% at 6 mmHg, 95% at 10 mmHg, and 175% at 14 mmHg.
• Exponential model: average increase of 7.45% per mmHg of insufflation pressure (CI: 4.7–10.2%).
• No systemic hemodynamic adverse effects were observed; MAP remained >60 mmHg throughout.
• Portal hypertension threshold (15 mmHg) predicted at ~6.4 mmHg insufflation pressure.
• No statistical impact from patient weight, pressure-to-weight ratio, or order of insufflation rounds.
• Measurement technique was feasible and safe, with only minor challenges (e.g., catheter kinking).
• The study supports use of the lowest insufflation pressure needed for visualization to avoid portal hypertension.
• Baseline portal pressures returned after desufflation, supporting comparison pre- and post-attenuation.

🔍 Key Findings

40 dogs underwent splenectomy using 16 bipolar vessel sealing devices (VSDs)
Devices were reused up to 4 times after handwashing and ethylene oxide (EtO) sterilization
Biologic debris was found in 100% of devices, specifically under the transection blade, even after a single use

• Mostly scant (14/16) or mild (2/16) debris

No devices or debris yielded positive aerobic culture after EtO sterilization
EtO sterilization proved microbiologically effective despite visible residue
Perioperative failure rate: 1 device (malfunctioned during first activation)

🔍 Key Findings

• TPLO mRUST scoring showed improved inter-rater reliability (ICC = 0.56) compared to subjective evaluation (Kappa = 0.33).
• Intra-rater reliability was similar for both methods (TPLO mRUST: 0.73, subjective: 0.72).
• TPLO mRUST scores ≥10/12 strongly correlated with radiographic union, as subjectively assessed (99% agreement).
• No significant difference in healing between first and second TPLO sides (P = .09), countering assumptions about load-bearing impact.
• Higher initial lameness scores and younger age were associated with higher TPLO mRUST scores, suggesting more robust healing in those groups.
• Postoperative complications were linked to lower TPLO mRUST scores, indicating impaired healing.
• Medial cortex was excluded from scoring due to plate obstruction, validating use of only 3 cortices for scoring.
• The TPLO mRUST system may standardize healing assessment, reducing subjective bias across specialties.

🔍 Key Findings

• Extreme brachycephalic breeds (EBBs) presented more acutely and at younger ages, most often with neurological signs compared to other breeds.
• Preoperative signs such as facial nerve paresis, vestibular syndrome, and Horner’s syndrome were significantly more common in EBBs.
• EBBs showed more severe imaging findings, including higher rates of otitis interna (46.3% vs. 8.5%) and brainstem changes (17.5% vs. 3%).
• Intraoperative complications were more frequent in EBBs (11.1% vs. 5.3%), but this difference did not reach statistical significance (p = .078).
• Perioperative complication rates did not differ significantly between EBBs and other breeds (23.5% vs. 29.3%).
• Surgical time was significantly longer in EBBs (median 115 vs. 95 minutes; p = .011).
• MRI or combined CT/MRI were more frequently used in EBBs, likely due to the higher prevalence of neurological signs.
• Despite anatomical challenges, complication rates in EBBs were comparable, supporting TECA-LBO safety in these breeds.